4.7 Editorial Material

Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes

Samuel I. Kim et al.

Summary: Cancer immunotherapy has revolutionized treatment in oncology, but its effectiveness varies among patients. Biomarkers predicting response include factors like tumor size and tumor burden. Therapeutic approaches for larger tumors involve reducing tumor burden and modulating the immune microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Oncology

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Jeffrey E. Gershenwald et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Article Oncology

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Alice Horisberger et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Letter Dermatology

Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes

Shenying Fang et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Article Oncology

C-Reactive Protein As a Marker of Melanoma Progression

Shenying Fang et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Oncology

Interleukin-6 signaling pathway in targeted therapy for cancer

Yuqi Guo et al.

CANCER TREATMENT REVIEWS (2012)

Review Oncology

Interleukin-6 and melanoma

Lise Hoejberg et al.

MELANOMA RESEARCH (2012)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)